WM Partners recently announced it had acquired Allergy Research Group (ARG) from Kikkoman Corp.
ARG, founded in 1979 and based in South Salt Lake, Utah, sells hypoallergenic supplements focused on addressing condition-specific issues to healthcare practitioners.
WM Partners, based in Aventura, Fla., is a middle-market private equity firm. Founded in 2015, the firm
Audax Private Equity recently announced it closed two new funds with a combined $7.8 billion.
Audax Private Equity Fund VII was oversubscribed, hitting its hard cap of $5.25 billion.
Audax Private Equity Origins Fund I closed with $774 million, exceeding its initial target. This fund is the firm’s first lower middle market strategy.
When combined
Comvest Partners has announced it has closed its latest fund at $2 billion.
The new fund, Comvest Credit Partners VI, exceeded its initial target of $1.7.
Comvest, based in West Palm Beach, Fla., is a middle-market private equity and credit investing firm. Its private equity strategy is to pursue control investments in multiple industries,
TPG has announced it has acquired Nextech from Thomas H. Lee Partners (THL) for $1.4 billion.
Nextech, based in Tampa, Fla., is a provider of clinical and administrative healthcare technology solutions for specialty physician practices. Founded in 1997, the company states it services more than 11,000 physicians in dermatology, ophthalmology, orthopedics, plastic surgery and med spa.
TPG is investing
TT Capital Partners (TTCP) has made a majority growth investment in Pyx Health, according to a news release.
Pyx Health, based in Tucson, Ariz., is the developer of a solution designed to address loneliness and social isolation. Founded in 2017, the company works with major payers as well as government, employer and community
McGuireWoods has long been an avid supporter of the advancement of professional women. As part of our initiative seeking to expand the leadership of women in private equity, we are continuing our series of profiling women leaders in private equity. We are hopeful that this series will serve to inspire other women to pursue their
Thoma Bravo has announced it has completed a growth investment in Bluesight.
Bluesight, based in Alexandria, Va., is a developer of software supporting the pharmacy supply chain. Founded in 2011, the company’s solutions include those for inventory management, controlled substance diversion prevention and medication purchasing.
Thoma Bravo, with offices in Chicago and San
Welsh, Carson, Anderson & Stowe (WCAS) has announced it has closed its latest fund with more than $5 billion in commitments.
The new fund, WCAS XIV, exceeded its target and the firm’s prior fund, which closed at $4 billion.
WCAS, based in New York, is a private equity firm focused exclusively on the healthcare
WindRose Health Investors has announced it has closed its latest fund with more than $1.4 billion in commitments.
The new fund, WindRose Health Investors VI, exceeded the size of its $705 million predecessor fund.
WindRose, based in New York, pursues control equity investments in healthcare companies. Founded in 2000, the firm invests in a broad range
Cathay Capital Private Equity has announced it has closed its latest fund with $270 million.
The new fund, Small Cap IV, will target control and minority investments in healthcare, consumer and software/technology companies across North America, Europe and Asia.
Cathay, with U.S. offices in New York and San Francisco, is a global private equity and venture capital